SILINTAN 25/pills recall
FDA recall D-0388-2026 · initiated Oct 20, 2025
ANTHONY TRINH, 123Herbals LLC recalled SILINTAN 25/pills in Oct 2025 — an FDA Class I recall (D-0388-2026) because Marketed Without an Approved NDA/ANDA: FDA analysis revealed the presence of undeclared meloxicam.
Most serious — a reasonable probability that use will cause serious harm or death.
Why it was recalled
Marketed Without an Approved NDA/ANDA: FDA analysis revealed the presence of undeclared meloxicam.
Sold unapproved, or found to contain something undeclared
The product should not have been on sale in this form — often a supplement found to contain a hidden prescription drug.
This is a manufacturing or quality failure, not a finding that the medicine is unsafe to take — across every recall we hold, none was issued for that reason. It does not mean the batch was harmless.
Is your product affected? Check the lot number
A recall covers only specific lots. Find the lot number and expiration date on your package and compare them to the affected codes below — if yours is not listed, it was not part of this recall.
Quantity recalled: N/A
Details
- Product
- SILINTAN 25/pills, packaged in a 25-count bottle, Shanghai Chinese Medical Works, Shanghai, China
- Recalling company
- ANTHONY TRINH, 123Herbals LLC
- Classification
- Class I
- Status
- Ongoing
- Type
- Voluntary: Firm initiated
- Distribution
- USA nationwide
- Initiated
- Oct 20, 2025
- FDA report date
- Mar 11, 2026
Frequently asked
- Was SILINTAN 25/pills recalled?
- ANTHONY TRINH, 123Herbals LLC recalled SILINTAN 25/pills in Oct 2025 — an FDA Class I recall (D-0388-2026) because Marketed Without an Approved NDA/ANDA: FDA analysis revealed the presence of undeclared meloxicam. Most serious — a reasonable probability that use will cause serious harm or death.
- Why was SILINTAN 25/pills recalled?
- Per the FDA enforcement record, the reason for recall D-0388-2026 was: Marketed Without an Approved NDA/ANDA: FDA analysis revealed the presence of undeclared meloxicam.
- Is a recalled SILINTAN 25/pills dangerous to take?
- An FDA recall removes specific lots from the market for a defined reason and does not by itself mean the medicine is unsafe for everyone — your specific lot may never have been affected. Most serious — a reasonable probability that use will cause serious harm or death. Check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This reproduces public FDA data and is not medical advice.
- Which lots of SILINTAN 25/pills are affected?
- Distributed: USA nationwide. The recall covers these lots — All lots within expiry. Check the lot number and expiration date on your package against this list; if yours is not listed, it was not part of recall D-0388-2026.